• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活体肾移植后早期高血压和糖尿病:一项全国队列研究。

Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.

机构信息

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD.

出版信息

Transplantation. 2019 Jun;103(6):1216-1223. doi: 10.1097/TP.0000000000002411.

DOI:10.1097/TP.0000000000002411
PMID:30247449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6428622/
Abstract

BACKGROUND

Living kidney donors have an increased risk of end-stage renal disease, with hypertension and diabetes as the predominant causes. In this study, we sought to better understand the timeline when these diseases occur, focusing on the early postdonation period.

METHODS

We studied 41 260 living kidney donors in the United States between 2008 and 2014 from the Scientific Registry of Transplant Recipients and modeled incidence rates and risk factors for hypertension and diabetes.

RESULTS

At 6 months, 1 year, and 2 years postdonation, there were 74, 162, and 310 cases, respectively, of hypertension per 10 000 donors. Donors who were older (per 10 y, adjusted incidence rate ratio [aIRR], 1.40; 95% confidence interval [CI], 1.29-1.51), male (aIRR, 1.31; 95% CI, 1.14-1.50), had higher body mass index (per 5 units, aIRR, 1.29; 95% CI, 1.17-1.43), and were related to their recipient (first-degree relative: aIRR, 1.28; 95% CI, 1.08-1.52; spouse: aIRR, 1.34; 95% CI, 1.08-1.66) were more likely to develop hypertension, whereas donors who were Hispanic/Latino were less likely (aIRR, 0.71; 95% CI, 0.55-0.93). At 6 months, 1 year, and 2 years, there were 2, 6, and 15 cases of diabetes per 10 000 donors. Donors who were older (per 10 y: aIRR, 1.42; 95% CI, 1.11-1.82), had higher body mass index (per 5 units: aIRR, 1.52; 95% CI, 1.04-2.21), and were Hispanic/Latino (aIRR, 2.45; 95% CI, 1.14-5.26) were more likely to develop diabetes.

CONCLUSIONS

In this national study, new-onset diabetes was rare, but 3% of donors developed hypertension within 2 years of nephrectomy. These findings reaffirm that disease pathways for kidney failure differ by donor phenotype and estimate the population most at-risk for later kidney failure.

摘要

背景

活体肾脏捐献者发生终末期肾病的风险增加,高血压和糖尿病是主要原因。在这项研究中,我们试图更好地了解这些疾病发生的时间线,重点关注捐赠后的早期阶段。

方法

我们研究了 2008 年至 2014 年间美国科学移植受者登记处的 41260 名活体肾脏捐献者,并对高血压和糖尿病的发病率和危险因素进行了建模。

结果

在捐赠后 6 个月、1 年和 2 年时,分别有 74、162 和 310 例高血压病例/每 10000 名供体。年龄较大(每 10 年,调整发病率比[aIRR],1.40;95%置信区间[CI],1.29-1.51)、男性(aIRR,1.31;95%CI,1.14-1.50)、体重指数较高(每增加 5 个单位,aIRR,1.29;95%CI,1.17-1.43)的供体以及与受者有关(一级亲属:aIRR,1.28;95%CI,1.08-1.52;配偶:aIRR,1.34;95%CI,1.08-1.66)的供体更有可能发生高血压,而西班牙裔/拉丁裔供体发生高血压的可能性较小(aIRR,0.71;95%CI,0.55-0.93)。在捐赠后 6 个月、1 年和 2 年时,每 10000 名供体中有 2、6 和 15 例糖尿病病例。年龄较大(每 10 年:aIRR,1.42;95%CI,1.11-1.82)、体重指数较高(每增加 5 个单位:aIRR,1.52;95%CI,1.04-2.21)以及西班牙裔/拉丁裔(aIRR,2.45;95%CI,1.14-5.26)的供体更有可能发生糖尿病。

结论

在这项全国性研究中,新发糖尿病罕见,但 3%的供体在肾切除术 2 年内发生高血压。这些发现再次证实,导致肾衰竭的疾病途径因供体表型而异,并估计了发生晚期肾衰竭风险最高的人群。

相似文献

1
Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.活体肾移植后早期高血压和糖尿病:一项全国队列研究。
Transplantation. 2019 Jun;103(6):1216-1223. doi: 10.1097/TP.0000000000002411.
2
Association Between Living Kidney Donor Postdonation Hypertension and Recipient Graft Failure.活体肾移植供者捐肾后高血压与受者移植物失功的关系。
Transplantation. 2020 Mar;104(3):583-590. doi: 10.1097/TP.0000000000002832.
3
Obesity increases the risk of end-stage renal disease among living kidney donors.肥胖会增加活体肾供者发生终末期肾病的风险。
Kidney Int. 2017 Mar;91(3):699-703. doi: 10.1016/j.kint.2016.10.014. Epub 2016 Dec 29.
4
Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.早期捐肾后肾功能与活体肾供者终末期肾病风险的关联。
JAMA Surg. 2020 Mar 1;155(3):e195472. doi: 10.1001/jamasurg.2019.5472. Epub 2020 Mar 18.
5
Implications of excess weight on kidney donation: Long-term consequences of donor nephrectomy in obese donors.超重对肾脏捐献的影响:肥胖供体肾切除术的长期后果。
Surgery. 2018 Nov;164(5):1071-1076. doi: 10.1016/j.surg.2018.07.015. Epub 2018 Aug 24.
6
Center Variation and Risk Factors for Failure to Complete 6 Month Postdonation Follow-up Among Obese Living Kidney Donors.肥胖活体肾捐献者 6 个月捐后随访失败的中心变异性和危险因素。
Transplantation. 2019 Jul;103(7):1450-1456. doi: 10.1097/TP.0000000000002508.
7
Factors Associated With Residual Kidney Function and Proteinuria After Living Kidney Donation in the United States.美国活体肾捐献后残余肾功能和蛋白尿的相关因素。
Transplantation. 2021 Feb 1;105(2):372-381. doi: 10.1097/TP.0000000000003210.
8
Causes and timing of end-stage renal disease after living kidney donation.活体肾捐献后终末期肾病的病因和发生时间。
Am J Transplant. 2018 May;18(5):1140-1150. doi: 10.1111/ajt.14671. Epub 2018 Mar 1.
9
End-stage renal disease among living-kidney donors: single-center experience.活体肾供者中的终末期肾病:单中心经验
Exp Clin Transplant. 2011 Feb;9(1):14-9.
10
Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.活体肾供体中由糖尿病、高血压和肾小球肾炎引起的终末期肾病模式。
Am J Transplant. 2016 Dec;16(12):3540-3547. doi: 10.1111/ajt.13917. Epub 2016 Jul 12.

引用本文的文献

1
Renal function outcomes in living kidney donors in a transplant center in Colombia.哥伦比亚一家移植中心活体肾供者的肾功能结局
SAGE Open Med. 2024 Nov 21;12:20503121241298139. doi: 10.1177/20503121241298139. eCollection 2024.
2
External Validation of Toulouse-Rangueil eGFR12 Prediction Model After Living Donor Nephrectomy.活体供肾切除术后 Toulouse-Rangueil eGFR12 预测模型的外部验证。
Transpl Int. 2023 Sep 7;36:11619. doi: 10.3389/ti.2023.11619. eCollection 2023.
3
The Living Kidney Donor Safety Study: Protocol of a Prospective Cohort Study.

本文引用的文献

1
Healthcare Costs for the Evaluation, Surgery, and Follow-Up Care of Living Kidney Donors.活体肾捐献者的评估、手术和随访护理的医疗费用。
Transplantation. 2018 Aug;102(8):1367-1374. doi: 10.1097/TP.0000000000002222.
2
Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation.人口健康、种族与活体供肾移植率。
Transplantation. 2018 Dec;102(12):2080-2087. doi: 10.1097/TP.0000000000002286.
3
Temporal trends, center-level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors.
活体肾供体安全性研究:一项前瞻性队列研究的方案
Can J Kidney Health Dis. 2022 Oct 28;9:20543581221129442. doi: 10.1177/20543581221129442. eCollection 2022.
4
Examining post-donation outcomes in Hispanic/Latinx living kidney donors in the United States: A systematic review.在美国对西班牙裔/拉丁裔活体肾脏捐献者的捐后结局进行评估:一项系统综述。
Am J Transplant. 2022 Jul;22(7):1737-1753. doi: 10.1111/ajt.17017. Epub 2022 Apr 18.
5
JCV viruria associates with suboptimal recovery of kidney function three years after living kidney donation.JCV 尿病毒血症与活体肾捐献 3 年后肾功能恢复不佳相关。
J Bras Nefrol. 2022 Jul-Sep;44(3):368-375. doi: 10.1590/2175-8239-JBN-2021-0148.
6
Practice Patterns in the Acceptance of Medically Complex Living Kidney Donors with Obesity, Hypertension, Family History of Kidney Disease, or Donor-Recipient Age Discrepancy.接受患有肥胖症、高血压、肾病家族史或供受者年龄差异的医学复杂性活体肾供者的实践模式。
Avicenna J Med. 2021 Nov 15;11(4):172-184. doi: 10.1055/s-0041-1736541. eCollection 2021 Oct.
7
Prevalence, Mechanisms, Treatment, and Complications of Hypertension Postliving Kidney Donation.活体肾移植后高血压的患病率、机制、治疗和并发症。
Biomed Res Int. 2021 Feb 4;2021:5460672. doi: 10.1155/2021/5460672. eCollection 2021.
8
Association Between Living Kidney Donor Postdonation Hypertension and Recipient Graft Failure.活体肾移植供者捐肾后高血压与受者移植物失功的关系。
Transplantation. 2020 Mar;104(3):583-590. doi: 10.1097/TP.0000000000002832.
9
One size does not fit all: understanding individual living kidney donor risk.一刀切并不适用所有人:了解个体活体肾脏捐献者的风险。
Pediatr Nephrol. 2021 Feb;36(2):259-269. doi: 10.1007/s00467-019-04456-8. Epub 2020 Jan 2.
10
Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation.活体肾捐献后的捐赠后估算肾小球滤过率及新发抗高血压药物使用情况。
Transplant Direct. 2019 Jul 25;5(8):e474. doi: 10.1097/TXD.0000000000000913. eCollection 2019 Aug.
时间趋势、中心水平差异,以及流行州肥胖率对肥胖活体肾脏供者接受度的影响。
Am J Transplant. 2018 Mar;18(3):642-649. doi: 10.1111/ajt.14519. Epub 2017 Oct 30.
4
Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up.活体肾脏捐献者表型与捐肾后随访可能性。
Transplantation. 2018 Jan;102(1):135-139. doi: 10.1097/TP.0000000000001881.
5
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.《肾脏疾病:改善全球预后(KDIGO)活体肾捐献者评估与管理临床实践指南》总结
Transplantation. 2017 Aug;101(8):1783-1792. doi: 10.1097/TP.0000000000001770.
6
Renal Consequences of Diabetes After Kidney Donation.肾移植后糖尿病的肾脏后果。
Am J Transplant. 2017 Dec;17(12):3141-3148. doi: 10.1111/ajt.14416. Epub 2017 Aug 14.
7
Expectations and Experiences of Follow-up and Self-Care After Living Kidney Donation: A Focus Group Study.活体肾移植后随访和自我护理的期望和体验:一项焦点小组研究。
Transplantation. 2017 Oct;101(10):2627-2635. doi: 10.1097/TP.0000000000001771.
8
The National Landscape of Living Kidney Donor Follow-Up in the United States.美国活体肾脏捐献者随访的国家概况。
Am J Transplant. 2017 Dec;17(12):3131-3140. doi: 10.1111/ajt.14356. Epub 2017 Jun 30.
9
Quantifying Postdonation Risk of ESRD in Living Kidney Donors.量化活体肾供者捐献后发生终末期肾病的风险。
J Am Soc Nephrol. 2017 Sep;28(9):2749-2755. doi: 10.1681/ASN.2016101084. Epub 2017 Apr 27.
10
Obesity increases the risk of end-stage renal disease among living kidney donors.肥胖会增加活体肾供者发生终末期肾病的风险。
Kidney Int. 2017 Mar;91(3):699-703. doi: 10.1016/j.kint.2016.10.014. Epub 2016 Dec 29.